Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2025Frontiers in EndocrinologyOpen Access

Correction: Efficacy and safety of tirzepatide for weight loss in patients with obesity or type 2 diabetes: a systematic review and meta-analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

QTQiru TianYSYi SongUniversity of Hong KongYDYan Deng

Discussion

Loading...

Member takes

Implication

Systematic review and meta-analysis shows tirzepatide improves weight loss in obesity and type 2 diabetes, indicating its potential effectiveness.

Key Points

  • Tirzepatide significantly reduces weight in patients with obesity or type 2 diabetes, emphasizing its effectiveness.
  • The meta-analysis included multiple studies, revealing enhanced weight loss compared to placebo groups.
  • This systematic review analyzed the efficacy and safety of tirzepatide over various studies on obesity and diabetes.
  • Findings suggest tirzepatide may be a valuable treatment option for weight management in these populations.

Cite This Study

Tian et al. (2025) studied this question.

synapsesocial.com/papers/68af79b67567bf4f94ff212fhttps://doi.org/10.3389/fendo.2025.1683829
View Full Paper
Ask AI
Bookmark
Share